(Q33410373)

26 July 2017

title

Evaluation of an enoxaparin dosing calculator using burn size and weight (English)

1 reference

26 July 2017

Iris Faraklas

1

1 reference

26 July 2017

Maureen Ghanem

series ordinal

2

1 reference

26 July 2017

Amalia Brown

series ordinal

3

1 reference

26 July 2017

Amalia Cochran

series ordinal

4

1 reference

26 July 2017

publication date

1 November 2013

1 reference

Journal of Burn Care and Research

26 July 2017

published in

1 reference

26 July 2017

volume

34

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

621-627

1 reference

Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E3182A2A855

Current practice of thromboprophylaxis in the burn population: a survey study of 84 US burn centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E3182A2A855

Practice guidelines for deep venous thrombosis prophylaxis in burns

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E3182A2A855

Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E3182A2A855

Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E3182A2A855

Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E3182A2A855

Enoxaparin and antifactor Xa levels in acute burn patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E3182A2A855

Antifactor Xa levels in four patients with burn injuries who received enoxaparin to prevent venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E3182A2A855

A prospective study of venous thromboembolism after major trauma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E3182A2A855

A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E3182A2A855

Creation and validation of a simple venous thromboembolism risk scoring tool for thermally injured patients: analysis of the National Burn Repository

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E3182A2A855

Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E3182A2A855

Pathophysiology and pharmacokinetics following burn injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E3182A2A855

Clinical Pharmacokinetics in Patients with Burns

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E3182A2A855

10.1097/BCR.0B013E3182A2A855

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference